Advertisement
Singapore markets closed
  • Straits Times Index

    3,297.55
    -26.98 (-0.81%)
     
  • S&P 500

    5,431.60
    -2.14 (-0.04%)
     
  • Dow

    38,589.16
    -57.94 (-0.15%)
     
  • Nasdaq

    17,688.88
    +21.28 (+0.12%)
     
  • Bitcoin USD

    66,264.55
    +208.44 (+0.32%)
     
  • CMC Crypto 200

    1,403.43
    -14.44 (-1.02%)
     
  • FTSE 100

    8,146.86
    -16.81 (-0.21%)
     
  • Gold

    2,339.00
    -10.10 (-0.43%)
     
  • Crude Oil

    78.15
    -0.30 (-0.38%)
     
  • 10-Yr Bond

    4.2130
    -0.0250 (-0.59%)
     
  • Nikkei

    37,993.17
    -821.39 (-2.12%)
     
  • Hang Seng

    17,978.30
    +36.52 (+0.20%)
     
  • FTSE Bursa Malaysia

    1,607.32
    -2.85 (-0.18%)
     
  • Jakarta Composite Index

    6,734.83
    -96.73 (-1.42%)
     
  • PSE Index

    6,383.70
    -7.13 (-0.11%)
     

GeneDx to Participate in Upcoming Investor Conferences

GeneDx Holdings Corp.
GeneDx Holdings Corp.

STAMFORD, Conn., May 22, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in two upcoming investor conferences in June:

  • Jefferies Healthcare Conference - New York City, New York
    Fireside chat on Wednesday, June 5 at 9:00 a.m. ET

  • 44th Annual Goldman Sachs Global Healthcare Conference - Miami, Florida
    Fireside chat on Monday, June 10 at 3:20 p.m. ET

Live and archived webcasts of the presentation will be available on the “Events” section of the GeneDx investor relations website at ir.genedx.com/news-events/events.

ADVERTISEMENT

About GeneDx

At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It all starts with a single test. For more information, please visit genedx.com and connect with us on LinkedIn, X, Facebook, and Instagram.

Investor Relations Contact:
investors@GeneDx.com

Media Contact:
press@GeneDx.com